SHENYANG, China, Feb. 25 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq:
SSRX), a leading China-based biotechnology company focused on researching,
developing, manufacturing and marketing biopharmaceutical products, today
announced that it will release financial results for the fourth quarter and
full year ended December 31, 2008 after the US market closes on Wednesday,
March 11, 2009.
Following the earnings announcement, 3SBio's senior management will host a
conference call at 5:00 am (Pacific) / 8:00 am (Eastern) / 8:00 pm
(Beijing/Hong Kong) on Thursday, March 12, 2009 to discuss its 2008 fourth
quarter and full year financial results and recent business activity.
The conference call may be accessed using the dial-in numbers below:
International Toll Dial-In Number: +65 673 57955
China (Landline): 800 819 0121
China (Mobile): 400 620 8038
U.K.: 080 823 46646
U.S.: 186 651 94004
H.K.: 800 933 053
Conference ID: 87494181
A telephone replay will be available shortly after the call until March 19,
2009, at:
International Dial-In Number: +61 2 8235 5000
U.S Dial-in Number: 186 6 2145 335
Conference ID: 87494181
A live webcast of the conference call and the replay will be available on
the investor relations page of 3SBio's website at
http://www.3sbio.com/en/News/ShowInfo_nnn11.aspx?ID=71 .
About 3SBio Inc.
3SBio Inc. is a leading, fully integrated biotechnology company focused on
researching, developing, manufacturing and marketing biopharmaceutical
products, primarily in China.
For more information, please visit 3SBio on the web at
http://www.3sbio.com .
For more information, please contact:
Investor Contact:
Bo Tan, CFO
3SBio Inc.
Tel: +86-24-2581-1820
Investor Relations (China):
Peter Schmidt
FD Beijing
Tel: +86-10-8591-1953
Investor Relations (US):
Evan Smith, or
John Capodanno
FD US
Tel: +1-212-850-5600
SOURCE 3SBio Inc.
